Provided by Tiger Fintech (Singapore) Pte. Ltd.

GoodRx Holdings, Inc.

4.80
+0.18504.01%
Volume:526.32K
Turnover:2.52M
Market Cap:1.84B
PE:119.88
High:4.84
Open:4.64
Low:4.63
Close:4.61
Loading ...

3 Reasons to Sell GDRX and 1 Stock to Buy Instead

StockStory
·
23 Apr

3 of Wall Street’s Favorite Stocks Showing Warning Signs

StockStory
·
17 Apr

Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

StockStory
·
17 Apr

Truist Cuts Price Target on GoodRx Holdings to $5.50 From $6.50, Keeps Hold Rating

MT Newswires Live
·
10 Apr

GoodRx price target lowered to $5.50 from $6.50 at Truist

TIPRANKS
·
10 Apr

GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

Business Wire
·
10 Apr

GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform

Zacks
·
08 Apr

GoodRx launches new e-commerce experience for prescriptions

Yahoo Finance
·
03 Apr

Allakos And 2 Other Promising Penny Stocks To Watch

Simply Wall St.
·
03 Apr

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Simply Wall St.
·
27 Mar

GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, Pharmd, as Chief Pharmacy Officer and Head of Clinical Engagement

THOMSON REUTERS
·
17 Mar

GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement

Business Wire
·
17 Mar

GoodRx Holdings, Inc. (GDRX): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock?

Insider Monkey
·
10 Mar

GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending

Business Wire
·
10 Mar

Balanced Outlook on GoodRx Holdings: Growth Potential Amidst Cautious Market Expectations

TIPRANKS
·
05 Mar

GoodRx Holdings Is Maintained at Overweight by Wells Fargo

Dow Jones
·
01 Mar

GoodRx Holdings (GDRX) Receives a Hold from Morgan Stanley

TIPRANKS
·
28 Feb

GoodRx Holdings Inc (GDRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
28 Feb

GoodRx (GDRX) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
28 Feb

GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales

Benzinga
·
28 Feb